These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28428645)

  • 1. Effect of tailored educational intervention to improve self-care maintenance and quality of life in postmenopausal osteoporotic women after a fragility fracture: the Guardian Angel® study.
    Basilici Zannetti E; D'Agostino F; Cittadini N; Feola M; Pennini A; Rao C; Vellone E; Tarantino U; Alvaro R
    Ig Sanita Pubbl; 2017; 73(1):65-76. PubMed ID: 28428645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of osteoporosis and bone fracture on health-related quality of life in postmenopausal women.
    Palacios S; Neyro JL; Fernández de Cabo S; Chaves J; Rejas J
    Climacteric; 2014 Feb; 17(1):60-70. PubMed ID: 23710562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone care nurses and the evolution of the nurse's educational function: the Guardian Angel(®) research project.
    Alvaro R; Pennini A; Zannetti EB; Cittadini N; Feola M; Rao C; D'Agostino F; Vellone E; Tarantino U
    Clin Cases Miner Bone Metab; 2015; 12(1):43-6. PubMed ID: 26136795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experience of field work learning for healthcare providers: new perspectives between disadvantages and critical issues.
    Pennini A; Cittadini N; Basilici Zannetti E; Cervoni C; Vellone E; D'Agostino F; Alvaro R
    Ann Ig; 2016; 28(4):252-62. PubMed ID: 27479761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left in limbo - Experiences and needs among postmenopausal women newly diagnosed with osteoporosis without preceding osteoporotic fractures: A qualitative study.
    Jakobsen PR; Hermann AP; Søndergaard J; Wiil UK; Dixon RF; Clemensen J
    Post Reprod Health; 2018 Mar; 24(1):26-33. PubMed ID: 29392982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of recent fracture on health-related quality of life in postmenopausal women.
    Brenneman SK; Barrett-Connor E; Sajjan S; Markson LE; Siris ES
    J Bone Miner Res; 2006 Jun; 21(6):809-16. PubMed ID: 16753011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing self-care in postmenopausal women with osteoporosis: The Guardian Angel® multicentric longitudinal study.
    Cittadini N; Basilici Zannetti E; Iovino P; De Maria M; D'Angelo D; Pennini A; Vellone E; Alvaro R
    Maturitas; 2022 Jul; 161():7-11. PubMed ID: 35688499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of and factors for self-reported fragility fractures among middle-aged and elderly women in rural Korea: an 11-year follow-up study.
    Ahn SK; Kam S; Chun BY
    J Prev Med Public Health; 2014 Nov; 47(6):289-97. PubMed ID: 25274003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F; Cimmino MA; Malavolta N; Carotti M; Di Matteo L; Scendoni P; Grassi W;
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognizing osteoporosis and its consequences in Quebec (ROCQ): background, rationale, and methods of an anti-fracture patient health-management programme.
    Bessette L; Ste-Marie LG; Jean S; Davison KS; Beaulieu M; Baranci M; Bessant J; Brown JP
    Contemp Clin Trials; 2008 Mar; 29(2):194-210. PubMed ID: 17766187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of vertebral fractures and quality of life in a sample of postmenopausal Brazilian women with osteoporosis.
    de Oliveira Ferreira N; da Silva RB; Arthuso M; Pinto-Neto AM; Caserta N; Costa-Paiva L
    Arch Osteoporos; 2012; 7():101-6. PubMed ID: 23225287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.
    Salaffi F; Malavolta N; Cimmino MA; Di Matteo L; Scendoni P; Carotti M; Stancati A; Mulé R; Frigato M; Gutierrez M; Grassi W;
    Clin Exp Rheumatol; 2007; 25(3):390-403. PubMed ID: 17631735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for the prevention and treatment of osteoporosis during early postmenopause.
    Delaney MF
    Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S12-23. PubMed ID: 16448872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closing the osteoporosis management gap in primary care: a secondary prevention of fracture programme.
    Brankin E; Mitchell C; Munro R;
    Curr Med Res Opin; 2005 Apr; 21(4):475-82. PubMed ID: 15899094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.